Cardio Diagnostics Holdings Inc
CDIO3.990USD
+0.120+3.10%
Fechamento 09/19, 16:00（ET）Cotações atrasadas em 15 min
6.94MValor de mercado
PerdaP/L TTM
Mais detalhes de Cardio Diagnostics Holdings Inc Empresa
Cardio Diagnostics Holdings, Inc. is an artificial intelligence-powered precision cardiovascular medicine company. The Company develops and commercializes a series of products for various types of cardiovascular disease and associated co-morbidities, including coronary heart disease (CHD), stroke, heart failure and diabetes, by leveraging its artificial intelligence (AI)-driven Integrated Genetic-Epigenetic Engine. Its first product, Epi+Gen CHD, is an epigenetics-based clinical blood test capable of assessing near-term (three-year) risk for CHD, and its second product, PrecisionCHD, is an epigenetics-based clinical blood test for the detection of CHD. CardioInnovate360 is a research use only (RUO) solution to support the discovery, development and validation of biopharmaceuticals for the assessment and management of cardiovascular diseases. HeartRisk is a cardiovascular risk intelligence platform that combines insights from anonymized and aggregated clinical cardiovascular data.
Informações da empresa
Código da empresaCDIO
Nome da EmpresaCardio Diagnostics Holdings Inc
Data de listagemNov 23, 2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Número de funcionários13
Tipo de títulosOrdinary Share
Fim do ano fiscalNov 23
Endereço311 W. Superior Street
CidadeCHICAGO
Bolsa de valoresNASDAQ Capital Market Consolidated
PaísUnited States of America
Código postal60645
Telefone18552269991
Site
Código da empresaCDIO
Data de listagemNov 23, 2021
CEODr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Executivos da empresa
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+0.03%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+0.03%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Ms. Wendy J. Betts
Ms. Wendy J. Betts
Independent Director
Independent Director
--
--
Mr. Peter K. Fung
Mr. Peter K. Fung
Independent Director
Independent Director
--
--
Mr. Paul F. Burton, J.D.
Mr. Paul F. Burton, J.D.
Independent Director
Independent Director
--
--
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Timur Dogan, Ph.D.
Mr. Timur Dogan, Ph.D.
Chief Technology Officer
Chief Technology Officer
4.28K
--
Dr. Warren Hosseinion, M.D.
Dr. Warren Hosseinion, M.D.
Non-Executive Chairman of the Board
Non-Executive Chairman of the Board
3.87K
+0.03%
Dr. Robert Philibert, M.D., Ph.D.
Dr. Robert Philibert, M.D., Ph.D.
Chief Medical Officer, Director
Chief Medical Officer, Director
3.25K
+0.03%
Mr. James Intrater
Mr. James Intrater
Independent Director
Independent Director
2.39K
--
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Dr. Meeshanthini V. (Meesha) Dogan, Ph.D.
Chief Executive Officer, Director
Chief Executive Officer, Director
--
--
Ms. Elisa Luqman, Esq., J.D.
Ms. Elisa Luqman, Esq., J.D.
Chief Financial Officer
Chief Financial Officer
--
--
Detalhamento da receita
Sem dados
Sem dados
Por Empresa
Por Região
Sem dados
Distribuição de ações
Atualizado em: ter, 19 de ago
Atualizado em: ter, 19 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Dogan (Meeshanthini)
3.13%
Bd Holding, Inc
3.00%
BlackRock Institutional Trust Company, N.A.
2.02%
Geode Capital Management, L.L.C.
0.76%
Susquehanna International Group, LLP
0.74%
Outro
90.35%
Investidores
Investidores
Proporção
Dogan (Meeshanthini)
3.13%
Bd Holding, Inc
3.00%
BlackRock Institutional Trust Company, N.A.
2.02%
Geode Capital Management, L.L.C.
0.76%
Susquehanna International Group, LLP
0.74%
Outro
90.35%
Tipos de investidores
Investidores
Proporção
Individual Investor
4.16%
Investment Advisor
3.61%
Corporation
3.00%
Investment Advisor/Hedge Fund
0.76%
Research Firm
0.43%
Hedge Fund
0.01%
Outro
88.03%
Participação acionária institucional
Atualizado em: ter, 1 de jul
Atualizado em: ter, 1 de jul
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q2
44
210.46K
12.10%
-12.90K
2025Q1
46
215.87K
12.62%
-11.61K
2024Q4
51
6.58M
12.62%
+556.91K
2024Q3
70
5.72M
21.51%
-4.06M
2024Q2
76
5.70M
26.20%
-6.56M
2024Q1
73
5.54M
28.62%
-6.62M
2023Q4
73
5.55M
28.89%
-5.24M
2023Q3
68
4.28M
41.11%
-6.26M
2023Q2
64
4.02M
40.37%
-6.37M
2023Q1
59
3.90M
40.53%
-6.83M
Ver Mais
Atividade dos acionistas
Nome
Ações detidas
Proporção
Variação
Var. %
Data
Dogan (Meeshanthini)
55.18K
3.17%
--
--
Mar 20, 2025
Bd Holding, Inc
52.88K
3.04%
--
--
Mar 20, 2025
BlackRock Institutional Trust Company, N.A.
35.57K
2.05%
--
--
Mar 31, 2025
Geode Capital Management, L.L.C.
13.17K
0.76%
+1.02K
+8.41%
Mar 31, 2025
The Vanguard Group, Inc.
12.42K
0.71%
+4.68K
+60.47%
Mar 31, 2025
Dogan (Timur)
4.28K
0.25%
-2.30K
-34.96%
Mar 20, 2025
Hosseinion (Warren)
3.87K
0.22%
--
--
Mar 20, 2025
Philibert (Robert)
3.25K
0.19%
--
--
Mar 20, 2025
Ver Mais
ETFs Relacionados
Nome
Proporção
Sem dados
Dividendo
Um total de
0.00
USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Sem dados
Desdobramento de ações
Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
